2019
DOI: 10.1016/j.ecl.2019.02.002
|View full text |Cite
|
Sign up to set email alerts
|

Gender Confirmation Surgery for the Endocrinologist

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
17
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(17 citation statements)
references
References 20 publications
0
17
0
Order By: Relevance
“…The thought is that exogenous estrogen increases the risk of thromboembolic events. However, this practice is controversial due to low incidence of thromboembolic events coupled with the deleterious effects of stopping hormone use in the transgender population (16). In our practice, we no longer stop exogenous hormone use, and we have not documented any changes in thromboembolic event frequency.…”
Section: Preoperative Guidelines Evaluation and Considerationsmentioning
confidence: 87%
See 4 more Smart Citations
“…The thought is that exogenous estrogen increases the risk of thromboembolic events. However, this practice is controversial due to low incidence of thromboembolic events coupled with the deleterious effects of stopping hormone use in the transgender population (16). In our practice, we no longer stop exogenous hormone use, and we have not documented any changes in thromboembolic event frequency.…”
Section: Preoperative Guidelines Evaluation and Considerationsmentioning
confidence: 87%
“…As previously mentioned, exogenous hormones should be taken for at least a year to prepare for surgical augmentation by maximizing growth of native tissues (15). Some groups advocate for stopping exogenous hormone use approximately two to four weeks prior to surgery (16). The thought is that exogenous estrogen increases the risk of thromboembolic events.…”
Section: Preoperative Guidelines Evaluation and Considerationsmentioning
confidence: 99%
See 3 more Smart Citations